Mengniu Dairy logo

Mengniu Dairy

Last updated January 21, 2026
37
Innovation Areas
2,105
Inventors
39
Collaborations

Bioactive lipid and casein enrichment: Mengniu DairyRecent Research Landscape

The technical lever is the encapsulation of specific bacterial agents to modulate arachidonic acid (ARA) levels in dairy matrices. This enables targeted metabolic support for bone and joint cartilage through bioactive lipid enrichment.

What technical problems is Mengniu Dairy addressing in Bioactive lipid and casein enrichment?

Poor micronutrient bioavailability

(4)evidences

The keywords highlight a specific focus on high iron absorption for infants. The underlying technical problem is the low bioavailability or poor absorption of essential minerals in cereal-based diets.

Ruminal degradation of dietary lipids

(4)evidences

Bioactive lipids like ARA and algal nutrients are often broken down by rumen microbes before they can be absorbed and secreted into milk. Protecting these compounds from premature digestion ensures higher nutritional transfer efficiency to the final dairy product.

Joint cartilage tissue degradation

(3)evidences

The keywords focus on the loss of structural integrity in bone and joint tissues. Addressing this biological failure mode enables the development of functional dairy products that prevent or reverse skeletal mobility limitations.

Insufficient neonatal immune development

(1)evidences

The specific peptides identified are bioactive sequences derived from milk proteins that address the deficiency of natural immunomodulatory factors in infants or immunocompromised subjects. Solving this provides a technical advantage by enhancing systemic pathogen defense and gut-associated lymphoid tissue maturation.